Kincell Bio · 20 hours ago
Data Entry Analyst
Kincell Bio engineers cells into therapies and is a contract development and manufacturing organization focused on supporting innovative companies developing immune cell therapies. They are seeking a highly organized Data Entry Analyst to support the Quality Control team by performing data entry, data trending activities, and maintaining laboratory data.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Perform preliminary review of environmental monitoring and laboratory documentation across all Kincell facilities
Perform data entry for all environmental monitoring results and laboratory data for all Kincell facilities
Generate and maintain spreadsheets to support data entry and reporting
Generate data trending reports to support investigations
Generate and maintain data trending graphs to support quarterly and annual data trending reports
Maintain organized and detailed records of entered data
Maintain confidentiality and security of sensitive company and customer information
Escalate any OOS trends to leadership immediately
Successfully work with internal and external stakeholders across multiple departments and organizations
Follow established data entry procedures and meet departmental deadlines
Support administrative tasks and projects as assigned
Comply with all company policies, procedures, and SOPs
Qualification
Required
High school diploma or equivalent required
At least 1 year related experience in data entry, office administration, or a related role
Advanced proficiency with Microsoft Office Suite (Excel, Word, Outlook) and data entry software
An equivalent combination of education and experience may be considered
Preferred
Previous quality control experience is a plus
Benefits
Competitive benefits
Company
Kincell Bio
Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding.
Funding
Current Stage
Growth StageTotal Funding
$58MKey Investors
Kineticos Ventures
2025-05-15Series Unknown· $22M
2023-07-26Series A· $36M
Recent News
2026-01-06
Precedence Research
2025-11-27
Company data provided by crunchbase